Radiological Sciences Research Seminar Series

Zhen Xu is the Li Ka Shing Endowed Professor of Biomedical Engineering and Professor of Radiology and Neurosurgery at the University of Michigan, Ann Arbor, Michigan. Her research focuses on ultrasound therapy and imaging. She is a pioneer and world leader of histotripsy and has developed histotripsy for cancer, neurological and cardiovascular applications. Her work has led to the FDA approval for non-invasive histotripsy treatment of liver tumors. She has been elected as a Fellow of the National Academy of Inventors (NAI), the American Institute of Medicine and Bioengineering (AIMBE) and IEEE. She received the IEEE Ultrasonics, Ferroelectrics, and Frequency Control (UFFC) Outstanding Paper Award in 2006, Frederic Lizzi Award from the International Society of Therapeutic Ultrasound (ISTU) in 2015, Lockhart Memorial Prize for Cancer Research in 2020, IEEE Carl Hellmuth Hertz Ultrasonics Award in 2024 and the Sony Women in Technology Award with Nature in 2026. She is the co-founder of HistoSonics, which is currently valued at $3 billion. She is named to the 2026 TIME100 Health list, honoring the 100 Most Influential Leaders in global health this year.